PP43 Factors Associated With Interrupting Treatment With Somatropin: Analysis Of Real-World Data From Argentina
Jorge Elgart, Carolina La Mura, Cintia Campelo, Lucila Rey-Ares · 2025
Read PP43 Factors Associated With Interrupting Treatment With Somatropin: Analysis Of Real-World Data From Argentina by Jorge Elgart, Carolina La Mura, Cintia Campelo, Lucila Rey-Ares (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12768719.txt.
Description
Jorge Elgart and co-authors study why children in Argentina stop growth hormone therapy, using records from a support program. Their 2025 study covers one thousand one hundred fifty-nine patients under sixteen. Stopping early is known to blunt growth gains, yet local data were missing.
Nearly fifty-seven percent stopped at least once. Sex, age, and region did not separate stoppers from stayers. Diagnosis and type of health coverage did. Non-medical causes drove about sixty-five percent of stops, led by delivery failures. Public coverage carried the highest stop risk and the weakest persistence. The authors say fixing supply and delivery chains could matter as much as any medical advice.
Catalog record
| CREATOR | Jorge Elgart, Carolina La Mura, Cintia Campelo, Lucila Rey-Ares |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |